In 2004, the interventional treatment of patent ductus arteriosus (PDA) is definitive and
curative. In current practice, coils are used for smaller PDA, and devices are employed for …

This review examines the biomaterials used in occlusion devices for cardiac defects, and
how the choice of these materials is dictated by design. Specifically, the devices used in …

A bibliometric analysis was performed to assess the quantitative trend of Patent Ductus
Arteriosus (PDA) treatment research, including intravenous injection of indomethacin and …

There are no reports on the effect of treatment of angiotensin-converting enzyme (ACE)
inhibitors in patients with transposition of the great arteries after the Mustard procedure. We …

Records from dogs (n= 125) that underwent attempted transarterial coil occlusion of patent
ductus arteriosus (PDA) at the University of California, Davis, between 1998 and 2003, were …

Background As new devices come into the market, percutaneous techniques improve and
interventionalists become more experienced; percutaneous closure gets more common in …

Objectives: This study assessed the feasibility and efficacy of implanting a new miniaturized
nitinol device to occlude the patent ductus arteriosus (PDA) in a newborn porcine model …

Objective—To compare the incidence of residual patent ductus arteriosus (PDA) flow after
ligation using 2 different dissection techniques: a standard dissection and a method …

BACKGROUND: Percutaneous closure of large persistent ductus arteriosus using the
Amplatzer® duct occluder is an alternative to surgery. However, this device is not …

Rapid advances in paediatric interventional cardiology allow transcatheter closure of patent
ductus arteriosus (PDA) in increasingly smaller patients. We describe a successful …